3rd Frontiers in Cancer Research
and
8th International Skin Carcinogenesis
Conferences

October 4-7, 2008
Holiday Inn
Austin, MN

CONFERENCE PROGRAM AND DESCRIPTION

Although never held jointly until now, each of these conferences has traditionally focused on novel aspects of cancer development in the skin and other organ sites. Technical advances in molecular and cellular biology and computational biology have led to increased understanding of the nature of the genetic and epigenetic changes that occur in the development of cancer. These advances have contributed to the clarification of the mechanisms by which normal cells progress to malignancy.

The goal of this joint conference is to provide a scientifically driven symposium involving didactic sessions and facilitating discussions regarding molecular and cellular targets of cancer causation and prevention and to provide a forum for exchange of the most recent and relevant information on the biological, cellular and molecular changes that occur during tumor development. Molecular mechanisms, risk stratification, and clinical intervention will be highlighted.

Sessions will focus on understanding how alterations in normal cell signaling and proliferation affect the expression of particular genetic changes, and how intrinsic and extrinsic factors can modify the neoplastic process. Newer technologies such as computer modeling of protein/protein interactions and small-molecule/protein interactions will also be highlighted and a substantial translational focus will also be included.

Conference Chairpersons:
Zigang Dong, M.D., Dr. P.H., Professor, The Hormel Institute, University of Minnesota
Susan M. Fischer, Ph.D., Professor, M.D. Anderson Cancer Center, University of Texas

Program Planning Committee:
Ann M. Bode, Ph.D., The Hormel Institute, University of Minnesota
G.Tim Bowden, Ph.D., University of Arizona Cancer Center
Paul Limburg, M.D., Mayo Clinic Cancer Center